Top Markets
Coin of the day
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.

Obalon Therapeutics, Inc.

OBLN
Rang in aandelen #34655
Obalon Therapeutics, Inc. operates as a fully integrated medical device... Obalon Therapeutics, Inc. operates as a fully integrated medical device enterprise, concentrating its efforts on creating and commercializing innovative solutions for individuals battling obesity. The company's flagship offering is the Obalon Balloon System, specifically engineered to promote weight reduction in obese patients. This comprehensive system incorporates an ingestible capsule that houses an inflatable balloon connected to a microcatheter. It also includes the Obalon Navigation System console, a specialized hardware and software platform used to precisely monitor and display the balloon's location during its placement. Further components are the Obalon Touch Inflation Dispenser, a semi-automated, portable instrument for inflating the balloon once it's correctly positioned, and a single-use canister containing a gas mixture. By February 27, 2020, Obalon Therapeutics managed three company-owned treatment centers situated in California. The firm was established in 2008 and bases its operations in Carlsbad, California.
Aandeelprijs
$3.05
Laatst gesynchroniseerd: 2021-06-15
Marktkapitalisatie
$5.16M
Verandering (1 dag)
-5.86%
Verandering (1 jaar)
0.00%
Land
US
Handel Obalon Therapeutics, Inc. (OBLN)

Categorie

P/B-ratio voor Obalon Therapeutics, Inc. (OBLN)
P/B-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Obalon Therapeutics, Inc. is de huidige P/B-ratio (TTM) 0. Eind 2026 had het bedrijf een P/B-ratio van 0.
P/B-ratiohistoriek voor Obalon Therapeutics, Inc. van 2026 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
3.7944 -
US
5.423 -
US
2.0146 -
IE
3.072 -
US
4.9725 -
US